ARCHIVES

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

This article is from The Cancer Letter archive.

Vol. 10 No. 15 | April 13, 1984

Download PDF Visit The Full Archive

Related Articles

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

No difference between digital or film mammograms, study finds.

September 23, 2005

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975